Cargando…

A study comparing baseline and best-corrected visual acuity after iodine-125 episcleral brachytherapy in uveal melanoma

PURPOSE: The aim of this study was to analyze the course of visual acuity (VA) in visual outcomes of patients treated with iodine-125 ((125)I) brachytherapy in our center, based on original VA before treatment. MATERIAL AND METHODS: Visual acuity was prospectively assessed using a case series of 305...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miguel, David, de Frutos, Jesús María, Alonso, Pilar, García-Álvarez, Ciro, Saornil, María Antonia, Diezhandino, Patricia, Garavis, Maria Isabel, Valencia, Patricia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2023
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669921/ https://www.ncbi.nlm.nih.gov/pubmed/38026075 http://dx.doi.org/10.5114/jcb.2023.132658

Ejemplares similares

Visual outcome after posterior uveal melanoma episcleral brachytherapy including radiobiological doses
por: Miguel, David, et al.
Publicado: (2018)

Regression of posterior uveal melanoma following iodine-125 plaque radiotherapy based on pre-treatment tumor apical height
por: Miguel, David, et al.
Publicado: (2021)

Treatment planning considerations for (125)I eye plaque brachytherapy
por: Miguel, David, et al.
Publicado: (2019)

Bilateral episcleral brachytherapy in simultaneous choroidal melanoma and circumscribed hemangioma
por: Correa-Pérez, María Encarnación, et al.
Publicado: (2013)

Radiobiological doses, tumor, and treatment features influence on outcomes after epiescleral brachytherapy. A 20-year retrospective analysis from a single-institution: part II
por: Miguel, David, et al.
Publicado: (2018)

Radiobiological doses, tumor, and treatment features influence on local control, enucleation rates, and survival after epiescleral brachytherapy. A 20-year retrospective analysis from a single-institution: part I
por: Miguel, David, et al.
Publicado: (2018)

Intra-operative ocular ultrasonography of iodine-125 brachytherapy plaques in patients with uveal melanoma
por: Ces, Antonio Piñeiro, et al.
Publicado: (2021)

Regression patterns of uveal melanoma after iodine-125 plaque brachytherapy
por: Fang, Rui, et al.
Publicado: (2021)

Silicone Oil and Iodine-125 Brachytherapy for Uveal Melanoma in High-Risk Patients
por: Lyons, Lance J, et al.
Publicado: (2019)

Three-year outcomes of uveal melanoma treated with intra-operative ultrasound-guided iodine-125 brachytherapy using custom-built eye plaques
por: Wong, Andrew J., et al.
Publicado: (2022)

Histopathology of Intraocular Medulloepithelioma following Iodine-125 Plaque Brachytherapy
por: Mohan, Sukriti, et al.
Publicado: (2022)

Visual Acuity, Contrast Sensitivity and Color Vision Three Years After Iodine-125 Brachytherapy for Choroidal and Ciliary Body Melanoma
por: Tsui, Irena, et al.
Publicado: (2015)

Evaluation of the surgical learning curve for I-125 episcleral plaque placement for the treatment of posterior uveal melanoma: a two decade review
por: Shah, Nisha V, et al.
Publicado: (2012)

Iodine-125 brachytherapy for brain tumours - a review
por: Schwarz, Silke B, et al.
Publicado: (2012)

Treatment of Uveal Melanoma With Radioactive Iodine 125 Implant Compared With Proton Beam Radiotherapy
por: Bolling, James P., et al.
Publicado: (2021)

Prostate brachytherapy with iodine-125 seeds: analysis of a single institutional cohort
por: Leite, Elton Trigo Teixeira, et al.
Publicado: (2019)

A Robust Oxygen Microbubble Radiosensitizer for Iodine‐125 Brachytherapy
por: Peng, Sheng, et al.
Publicado: (2021)

Effect of neoadjuvant iodine-125 brachytherapy upon resection of glioma
por: Wang, Congxiao, et al.
Publicado: (2022)

Regression Rate of Posterior Uveal Melanomas Following Iodine-125 Plaque Radiotherapy
por: Demirci, Hakan, et al.
Publicado: (2015)

Episcleritis
por: Cotter, R. O.
Publicado: (1887)

Episcleral plaque brachytherapy using ‘BARC I-125 Ocu-Prosta seeds’ in the treatment of intraocular tumors: A single-institution experience in India
por: Shah, Parag K, et al.
Publicado: (2012)

Experimental study of pelvic perioperative brachytherapy with iodine 125 seeds (I-125) in an animal model
por: Brun, Thomas, et al.
Publicado: (2018)

Radiation retinopathy following episcleral brachytherapy for intraocular tumors: Current treatment options
por: Mularska, Weronika, et al.
Publicado: (2023)

Monte Carlo dosimetry of a novel Yttrium‐90 disc source for episcleral brachytherapy
por: Chang, Xiangyun, et al.
Publicado: (2023)

The prognostic implication of visual acuity at the time of uveal melanoma diagnosis
por: Asplund, Elin, et al.
Publicado: (2022)

Stereotactic iodine-125 brachytherapy for brain tumors: temporary versus permanent implantation
por: Ruge, Maximilian I, et al.
Publicado: (2012)

Treasure of the Past IX: Exposure Standardization of Iodine-125 Seeds Used for Brachytherapy
por: Loftus, T. P.
Publicado: (2001)

Value of CT-MRI fusion in iodine-125 brachytherapy for high-grade glioma
por: Gao, Yang, et al.
Publicado: (2017)

Analysis of immune status after iodine-125 permanent brachytherapy in prostate cancer
por: Du, E, et al.
Publicado: (2017)

Permanent iodine-125 brachytherapy for patients with progressive or recurrent high-grade gliomas
por: Wang, Congxiao, et al.
Publicado: (2020)

Safety and efficacy of iodine-125 seed strand for intraluminal brachytherapy on ureteral carcinoma
por: Bi, Yonghua, et al.
Publicado: (2023)

Microincisional vitrectomy for retinal detachment in I-125 brachytherapy-treated patients with posterior uveal malignant melanoma
por: Lonngi, Marcela, et al.
Publicado: (2013)

Reduced blood flow by laser speckle flowgraphy after (125)I-plaque brachytherapy for uveal melanoma
por: Tamplin, Michelle R., et al.
Publicado: (2022)

Deterioration of Visual Acuity after Brachytherapy and Proton Therapy of Uveal Melanoma, and Methods of Counteracting This Complication Based on Recent Publications
por: Jarczak, Jakub, et al.
Publicado: (2023)

Measurement of the strength of iodine-125 seed moving at unknown speed during implantation in brachytherapy
por: Tanaka, Kenichi, et al.
Publicado: (2014)

Changes in lower urinary tract symptoms after iodine-125 brachytherapy for prostate cancer
por: Onishi, Kenta, et al.
Publicado: (2018)

Efficacy and safety of iodine-125 brachytherapy combined with chemotherapy in the treatment of advanced NSCLC in the elderly
por: Wu, Chunrong, et al.
Publicado: (2018)

Correction to: Permanent iodine-125 brachytherapy for patients with progressive or recurrent high-grade gliomas
por: Wang, Congxiao, et al.
Publicado: (2020)

Iodine-(125) plaque brachytherapy for aggressive squamous cell carcinoma with corneal and scleral invasion
por: Kaufman, Aaron R., et al.
Publicado: (2022)

Outcomes and Control Rates for I-125 Plaque Brachytherapy for Uveal Melanoma: A Community-Based Institutional Experience
por: Wagner, Aaron, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_k4kue9hi3edel2880gc0eb93e0